A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2500

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Progressive Relapsing Multiple Sclerosis

Interventions

DRUG: Tolebrutinib
DRUG: Placebo
DRUG: Teriflunomide

Sponsor

Sanofi